| pubmed-article:19615828 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19615828 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
| pubmed-article:19615828 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:19615828 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
| pubmed-article:19615828 | lifeskim:mentions | umls-concept:C0032790 | lld:lifeskim |
| pubmed-article:19615828 | lifeskim:mentions | umls-concept:C0033727 | lld:lifeskim |
| pubmed-article:19615828 | lifeskim:mentions | umls-concept:C0392752 | lld:lifeskim |
| pubmed-article:19615828 | lifeskim:mentions | umls-concept:C2347946 | lld:lifeskim |
| pubmed-article:19615828 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:19615828 | pubmed:dateCreated | 2010-2-17 | lld:pubmed |
| pubmed-article:19615828 | pubmed:abstractText | To study the potential reduction of dose to organs at risk (OARs) with intensity-modulated proton radiotherapy (IMPT) compared with intensity-modulated radiotherapy (IMRT) and three-dimensional conformal radiotherapy (3D-CRT) photon radiotherapy for left-sided breast cancer patients. | lld:pubmed |
| pubmed-article:19615828 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19615828 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19615828 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19615828 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19615828 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19615828 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:19615828 | pubmed:issn | 1879-355X | lld:pubmed |
| pubmed-article:19615828 | pubmed:author | pubmed-author:HugEugen BEB | lld:pubmed |
| pubmed-article:19615828 | pubmed:author | pubmed-author:AresCarmenC | lld:pubmed |
| pubmed-article:19615828 | pubmed:author | pubmed-author:LomaxAntony... | lld:pubmed |
| pubmed-article:19615828 | pubmed:author | pubmed-author:GoiteinGudrun... | lld:pubmed |
| pubmed-article:19615828 | pubmed:author | pubmed-author:GruberGuenthe... | lld:pubmed |
| pubmed-article:19615828 | pubmed:author | pubmed-author:BodisStephanS | lld:pubmed |
| pubmed-article:19615828 | pubmed:author | pubmed-author:KhanShakaS | lld:pubmed |
| pubmed-article:19615828 | pubmed:author | pubmed-author:MacartainAnne... | lld:pubmed |
| pubmed-article:19615828 | pubmed:author | pubmed-author:HeubergerJürg... | lld:pubmed |
| pubmed-article:19615828 | pubmed:author | pubmed-author:LuttersGerdG | lld:pubmed |
| pubmed-article:19615828 | pubmed:copyrightInfo | Copyright (c) 2010 Elsevier Inc. All rights reserved. | lld:pubmed |
| pubmed-article:19615828 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19615828 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:19615828 | pubmed:volume | 76 | lld:pubmed |
| pubmed-article:19615828 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19615828 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19615828 | pubmed:pagination | 685-97 | lld:pubmed |
| pubmed-article:19615828 | pubmed:meshHeading | pubmed-meshheading:19615828... | lld:pubmed |
| pubmed-article:19615828 | pubmed:meshHeading | pubmed-meshheading:19615828... | lld:pubmed |
| pubmed-article:19615828 | pubmed:meshHeading | pubmed-meshheading:19615828... | lld:pubmed |
| pubmed-article:19615828 | pubmed:meshHeading | pubmed-meshheading:19615828... | lld:pubmed |
| pubmed-article:19615828 | pubmed:meshHeading | pubmed-meshheading:19615828... | lld:pubmed |
| pubmed-article:19615828 | pubmed:meshHeading | pubmed-meshheading:19615828... | lld:pubmed |
| pubmed-article:19615828 | pubmed:meshHeading | pubmed-meshheading:19615828... | lld:pubmed |
| pubmed-article:19615828 | pubmed:meshHeading | pubmed-meshheading:19615828... | lld:pubmed |
| pubmed-article:19615828 | pubmed:meshHeading | pubmed-meshheading:19615828... | lld:pubmed |
| pubmed-article:19615828 | pubmed:meshHeading | pubmed-meshheading:19615828... | lld:pubmed |
| pubmed-article:19615828 | pubmed:meshHeading | pubmed-meshheading:19615828... | lld:pubmed |
| pubmed-article:19615828 | pubmed:meshHeading | pubmed-meshheading:19615828... | lld:pubmed |
| pubmed-article:19615828 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:19615828 | pubmed:articleTitle | Postoperative proton radiotherapy for localized and locoregional breast cancer: potential for clinically relevant improvements? | lld:pubmed |
| pubmed-article:19615828 | pubmed:affiliation | Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland. carmen.ares@psi.ch | lld:pubmed |
| pubmed-article:19615828 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19615828 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:19615828 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
